FindTrial
Sign In

Randomised controlled trial of Normacol for faecal incontinence after pelvic radiotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN15517721
Enrollment
Unknown
Registered
2005-09-30
Start date
2003-07-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Faecal incontinence Signs and Symptoms Faecal incontinence

Interventions

Normacol versus placebo.

Sponsors

Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Any patient with episodes of active or passive faecal incontinence one or more per month at least 3 months after the completion of pelvic radiotherapy who did not have pre-existing incontinence.

Exclusion criteria

Exclusion criteria: 1. Patients unlikely to survive 1 year 2. Patients unable to give informed consent

Design outcomes

Primary

MeasureTime frame
Would be the first study of any kind to report benefit for any treatment in this group of patients with this condition.—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026